Peter Madrid, Ph.D., is head of the Biosciences Division Applied Research group in Menlo Park. His team focuses on developing innovative technologies to accelerate the discovery of drugs and diagnostics for significant unmet medical needs. The group has produced a pipeline of drug candidates, primarily in the areas of cancer and infectious diseases.

Dr. Madrid has led multidisciplinary teams conducting research projects on infectious disease drug discovery, automated chemical synthesis, high-throughput screening methodologies and AI-driven drug discovery. He has published numerous papers in the field of anti-infectives drug discovery and is an inventor on several patents on drug discovery technologies.

He received his Ph.D. in chemistry and chemical biology from the University of California, San Francisco, and his B.S. in chemistry from the University of California, Santa Cruz.

View Dr. Madrid’s publications on PubMed and Google Scholar.